Home
NewsNewsOverture Life and CEGYR introduced the first Automated Embryology Center of Excellence to standardize IVF lab processes using robotics and data-driven workflows. By reducing manual variability, the model supports high-volume fertility networks, improves reproducibility, eases embryologist workload, and creates a scalable blueprint for consistent outcomes across global clinics and future-ready clinical operations worldwide.
In a bold move that blends cutting-edge tech with clinical grit, Overture Life, a pioneer in robotic reproductive technologies, has teamed up with Argentina’s CEGYR fertility network to launch what they’re calling a new standard for highly automated embryology operations.
The collaboration places robot-assisted lab systems and smart workflow tools at the core of embryology services across CEGYR’s high-volume fertility clinics and egg-bank facilities. The goal: reduce the age-old problem of inconsistent outcomes tied to manual lab techniques, while opening doors to significantly higher throughput and reliability.
Together, the partners are introducing robotic vitrification, an automated freezing process, along with standardized dish preparation and emerging non-invasive embryo assessment technologies. These systems promise predictable lab performance even as IVF demand outpaces the global supply of skilled embryologists.
CEGYR, with decades of reproductive medicine experience and thousands of procedures annually, will serve as the proving ground for this new model. By collecting real-world data under regulated clinical conditions, the centre hopes to show that automation can slash cycle-to-cycle variability, stabilize lab workflows, and free clinical teams to focus on patient care rather than repetitive manual tasks.
Overture Life’s leadership notes that reproducibility should be built into the system itself, not left to the day-to-day skills of individual technicians. CEGYR’s CEO adds that higher volumes don’t have to mean looser standards; smart automation can equip clinics to grow without sacrificing precision.
With global IVF demand climbing steeply, this alliance may become a template for other large fertility networks looking to balance quality with scale through technological innovation.
Fertility care leader IVI RMA North America announces a new partnership with Island Reproductive Services
Overture Life’s DaVitri fertility automation platform gains CE Mark, paving the way for wider IVF and egg freezing access in Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
Technology-Enabled Cryostorage is transforming fertility storage as Reprotech and TMRW combine expertise in digital specimen management and biorepository services. The partnership enhances scalability, safety, and efficiency while supporting clinics with advanced solutions. This strategic move positions the combined company to lead innovation and meet growing global demand in cryostorage services.
CDSCO Orders on IVF Medical Devices reinforce strict regulatory oversight across India’s fertility sector. The directive mandates licensing compliance under existing laws, ensuring IVF and ART devices meet safety and quality standards. This move aims to curb unauthorized sales, strengthen enforcement, and bring greater accountability to medical device usage in reproductive healthcare.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
Before taking a call on IVF, survey conducted in the U.S., UK, Ireland, and Canada suggests that people are looking for complete & less expensive options to treat root causes of infertility.
